ResMed Inc (RMD) stock

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3012% below fair value

$239.53+0.64 (+0.27%)

Close on Nov 13, 2026Market cap $33.69BP/E 21.8Yield 1.00%

ResMed statistics

111 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Jan 28, 2027 (estimated, after the close)
Last ex-dividend date: Aug 20, 2026
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $33.69B; $498.53M
Enterprise Value: $32.84B; $433.11M
PE Ratio: 21.82; 29.52
PS Ratio: 5.88; 2.94
PB Ratio: 5.66; 3.24
P/TBV Ratio: 12.97; 4.81
P/FCF Ratio: 20.94; 26.31
P/OCF Ratio: 19.02; 21.97

Enterprise valuationIndustry

EV / Sales: 5.73; 2.60
EV / EBITDA: 15.72; 18.41
EV / EBIT: 17.35; 24.14
EV / FCF: 20.41; 27.51

Share statisticsIndustry

Shares Outstanding: 141M; 43M
Shares Change (YoY): -1.37%; 3.32%
Shares Change (QoQ): -2.50%; 0.20%
Float: 139M; 37M
Shares Held by Insiders: 1.31%; 10.5%
Shares Held by Institutions: 71.1%; 60.5%

Short sellingIndustry

Short Interest: 10M; –
Short Interest Change: -12.2%; -2.57%
Days to Cover: 7.05; 3.94

Stock price statisticsIndustry

52-Week High: $277.67; –
52-Week Low: $180.26; –
20-Day Moving Average: $241.81; –
50-Day Moving Average: $232.16; –
200-Day Moving Average: $223.87; –
Average True Range (14): $7.32; –
Price Change (1 Week): 1.80%; 0.99%
Price Change (1 Month): -1.11%; -3.52%
Price Change (3 Months): 8.69%; -7.86%
Price Change (6 Months): 18.6%; -1.12%
Price Change (YTD): -0.56%; -2.92%
Price Change (1 Year): -5.27%; -1.37%
Price Change (3 Years): 62.6%; 3.24%
Price Change (5 Years): -6.00%; -50.4%
Price Change (10 Years): 309.0%; 58.9%
Average Volume (10 Days): 1M; –
Average Volume (20 Days): 1M; –
Average Volume (90 Days): 1M; –
Relative Volume: 0.63; 0.76
Relative Strength Index (14): 52.4; 46.7
Volatility (1 Year): 30.8%; 64.2%
Beta (5 Years): 0.92; 1.04

MarginsIndustry

Gross Margin: 61.1%; 55.9%
Operating Margin: 33.0%; -5.12%
Pretax Margin: 35.1%; -2.32%
Profit Margin: 27.8%; -9.29%
EBITDA Margin: 36.4%; -2.52%
FCF Margin: 28.1%; 0.65%

Returns on capitalIndustry

Return on Equity (ROE): 26.4%; -17.3%
Return on Assets (ROA): 19.3%; -12.3%
Return on Invested Capital (ROIC): 29.7%; -2.83%
Return on Capital Employed (ROCE): 27.5%; -8.13%

Financial positionIndustry

Current Ratio: 2.65; 2.49
Quick Ratio: 1.50; 1.53
Debt / Equity: 0.03; 0.42
Debt / EBITDA: 0.08; 2.23
Debt / FCF: 0.10; 3.62
Net Debt / EBITDA: -0.41; 1.49

GrowthIndustry

Revenue Growth (YoY): 9.04%; 9.42%
Net Income Growth (YoY): 10.8%; 13.4%
EPS Growth (YoY): 12.4%; 15.1%
FCF Growth (YoY): -9.02%; 7.64%
Revenue Growth (3Y CAGR): 10.2%; 7.08%
Revenue Growth (5Y CAGR): 12.1%; 11.8%
EPS Growth (3Y CAGR): 19.6%; 3.11%
EPS Growth (5Y CAGR): 26.3%; 7.64%

EfficiencyIndustry

Asset Turnover: 0.69; 0.59
Inventory Turnover: 2.27; 2.20
Revenue Per Employee: $504.19K; $331.99K
Profits Per Employee: $140.12K; -$46.47K
Employee Count: 11,370; 193
WACC: 9.66%; 9.91%

Income statement (TTM)Industry

Revenue: $5.73B; $108.17M
Gross Profit: $3.50B; $62.29M
Operating Income: $1.89B; -$3.72M
Pretax Income: $2.01B; -$1.83M
Net Income: $1.59B; -$6.19M
EBITDA: $2.09B; -$1.98M
EPS (Diluted): $10.98; -$0.11

Balance sheetIndustry

Cash & Short-Term Investments: $1.01B; $38.97M
Total Debt: $159.98M; $96.00M
Net Cash (Debt): $850.77M; $3.95M
Net Cash Per Share: $6.05; $0.26
Equity (Book Value): $5.95B; $63.80M
Book Value Per Share: $42.28; $3.26
Tangible Book Value: $2.60B; $11.61M
Working Capital: $2.18B; $57.32M

Cash flow (TTM)Industry

Operating Cash Flow: $1.77B; -$483.87K
Capital Expenditures: -$162.06M; -$3.94M
Free Cash Flow: $1.61B; -$238.00K
FCF Per Share: $11.44; -$0.00

Dividends and yieldsIndustry

Earnings Yield: 4.73%; -4.76%
FCF Yield: 4.78%; 0.28%
Dividend Yield: 1.00%; 0.79%
Buyback Yield: 4.20%; 0.80%
Shareholder Yield: 5.21%; 1.12%
Dividend Per Share: $2.40; $0.72
Dividend Growth (YoY): 13.2%; 4.88%
Years of Dividend Growth: 5; 0
Payout Ratio: 22.4%; 24.3%
FCF Payout Ratio: 22.2%; 22.0%

Taxes and interestIndustry

Income Tax: $418.61M; $1.55M
Effective Tax Rate: 20.8%; 18.0%

Scores and fair valueIndustry

Graham Number: $102.21; $38.11
Graham Upside: -57.3%; -56.1%
Altman Z-Score: 12.00; 2.47
Piotroski F-Score: 6; 5
Beneish M-Score: -2.67; -2.64
Lynch Fair Value: $274.50; –
Lynch Upside: 14.6%; -45.2%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	RMD	S&P 500	Difference	RMD per year	S&P 500 per year
1 month	+1.9%	-3.0%	+4.9 pts
3 months	+5.9%	-2.8%	+8.7 pts
Year to date	+0.3%	+11.5%	−11.2 pts
1 year	-4.2%	+13.5%	−17.7 pts
3 years	+72.1%	+77.7%	−5.6 pts	+19.8%	+21.1%
5 years	-1.8%	+72.6%	−74.4 pts	-0.4%	+11.5%
10 years	+344.5%	+308.2%	+36.4 pts	+16.1%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

10M RMD shares were sold short on Oct 30, 2026, down 12.2% from the previous report. At recent volumes it would take 7.0 days to buy them back. Over the last 20 sessions, 68.5% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	10,471,435	-12.2%	1,485,271	7.0
Oct 15, 2026	11,920,328	-6.7%	966,537	12.3
Sep 30, 2026	12,783,009	-10.0%	1,294,339	9.9
Sep 15, 2026	14,203,907	+8.6%	1,209,593	11.7
Aug 31, 2026	13,073,165	+2.2%	1,462,283	8.9
Aug 14, 2026	12,794,915	-18.4%	1,727,103	7.4
Jul 31, 2026	15,676,616	+15.8%	1,104,429	14.2
Jul 15, 2026	13,541,103	-10.4%	1,726,912	7.8
Jun 30, 2026	15,104,487	+17.0%	1,778,242	8.5
Jun 15, 2026	12,915,210	+8.7%	1,431,442	9.0
May 29, 2026	11,881,847	-12.5%	1,618,671	7.3
May 15, 2026	13,573,617	+10.4%	1,612,973	8.4